pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

(2010) Christine Hostetter et al.   CANCER BIOLOGY & THERAPY

The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase

(2009) C. L. Costantino et al.   CANCER RESEARCH

The ‘RNA-binding ome’: future implications for chemotherapeutic efficacy

(2009) Jonathan R Brody et al.   Future Oncology

PHAPI/pp32 Suppresses Tumorigenesis by Stimulating Apoptosis

(2009) Wei Pan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Survival and Prognostic Factors of Unresectable Pancreatic Cancer

(2009) Joo Kyung Park et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence

(2009) Jie Yi et al.   NUCLEIC ACIDS RESEARCH

Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer

(2008) J. M. Winter et al.   CLINICAL CANCER RESEARCH

Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis

(2008) Rachid Mazroui et al.   JOURNAL OF CELL BIOLOGY

MKP-1 mRNA Stabilization and Translational Control by RNA-Binding Proteins HuR and NF90

(2008) Y. Kuwano et al.   MOLECULAR AND CELLULAR BIOLOGY

Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine

(2006) Akira Sawaki et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY